Table 2.
Effect of STZ injection on metabolic parameters.
| WT | PAR2−/− | |||
|---|---|---|---|---|
| NT (n = 14) |
STZ (n = 9) |
NT (n = 9) |
STZ (n = 8) |
|
| Body weight, gram | 26.2 ± 0.4 | 17.3 ± 0.7*** | 26.2 ± 1.2 | 17.3 ± 0.5*** |
| Blood glucose, mg/dl | 151.4 ± 6.8 | 630.4 ± 28.1*** | 135.2 ± 8.5 | 507.8 ± 29.7*** |
| Total cholesterol, mg/dl | 110.2 ± 3.0 | 439.9 ± 88.3*** | 117.6 ± 3.5 | 417.1 ± 33.7*** |
| Triglyceride, mg/dl | 114.9 ± 8.9 | 403.1 ± 110.3** | 141.3 ± 30.5 | 461.5 ± 100.5** |
| HDL-Cholesterol, mg/dl | 67.7 ± 1.9 | 149.8 ± 15.3*** | 74.6 ± 2.3 | 153.1 ± 7.6*** |
WT; wild-type, NT; non-treatment, STZ; streptozotocin,HDL; high-density lipoprotein.
*P < 0.05, **P < 0.01, and ***P < 0.001 vs. NT.